Neueste Versuche


EudraCT Number: 2011-001692-39 Sponsor Protocol Number: CFTY720DDE06 Start Date:
Sponsor Name: Novartis Pharma GmbH
Full Title: A 21-week, multicenter, open label study to evaluate the safety and tolerability profile of the combination of a SSRI or SNRI antidepressive therapy with oral fingolimod in the treatment of RRMS pa...
Medical condition: Multiple Sclerosis Depression
Disease: Version SOC Term Classification Code Term Level
14.1 10037175 - Psychiatric disorders 10012378 Depression PT
14.1 10029205 - Nervous system disorders 10063399 Relapsing-remitting multiple sclerosis PT
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2008-003575-47 Sponsor Protocol Number: BP21572 Start Date:
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: A randomized, double-blind, placebo controlled, parallel group study to investigate the effect of Taspoglutide on gastric emptying measured by a paracetamol test after single dose and after multipl...
Medical condition: Patients with Type 2 diabetes
Disease: Version SOC Term Classification Code Term Level
9.1 10012601 Diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2011-002261-38 Sponsor Protocol Number: P100504 Start Date:
Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Full Title:
Medical condition:
Disease: Version SOC Term Classification Code Term Level
14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10038683 Respiratory disorder PT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-000358-11 Sponsor Protocol Number: CAMN107DDE06 Start Date:
Sponsor Name: Novartis Pharma GmbH
Full Title: An open-label, multi-center, single-arm study to evaluate the efficacy of nilotinib in adult patients with metastatic or unresectable gastrointestinal stromal tumors in first line treatment
Medical condition: metastatic or unresectable gastrointestinal stromal tumor
Disease: Version SOC Term Classification Code Term Level
20.0 100000004864 10062427 Gastrointestinal stromal tumor LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) ES (Ongoing) FI (Completed) IT (Ongoing) FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2011-003795-36 Sponsor Protocol Number: CERL080ADE27 Start Date:
Sponsor Name: Novartis Pharma GmbH
Full Title: Multi-center, open-label, prospective, randomized, parallel group study investigating a tacrolimus Hexal® based regimen versus a Prograf® based regimen in de novo renal transplant recipients
Medical condition: renal transplantation
Disease: Version SOC Term Classification Code Term Level
18.0 100000004865 10050436 Prophylaxis against renal transplant rejection LLT
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2014-000728-97 Sponsor Protocol Number: EMR200109_635 Start Date:
Sponsor Name: Academic MS Center Limburg
Full Title: Regulation of the stress-axis by vitamin D3 in subjects with multiple sclerosis; a double-blinded, randomized, placebo-controlled study
Medical condition: Relapsing remitting multiple sclerosis
Disease: Version SOC Term Classification Code Term Level
18.1 10029205 - Nervous system disorders 10063399 Relapsing-remitting multiple sclerosis PT
Population Age: Adults Gender: Female
Trial protocol: NL (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2005-001546-17 Sponsor Protocol Number: GBG40 Start Date:
Sponsor Name: German Breast Group
Full Title: GeparQuattro: A randomized phase III study exploring the efficacy of Capecitabine given concomitantly or in sequence to EC - Doc with or without Trastuzumab as neoadjuvant treatment of primary brea...
Medical condition: Primary breast cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2008-001721-34 Sponsor Protocol Number: 20050197 Start Date:
Sponsor Name: Amgen Inc
Full Title: A Phase 2, Randomised, Double-blind, Placebo-controlled, Dose-finding Study of Darbepoetin alfa for the Treatment of Anemia in Paediatric Subjects with Solid Tumours Receiving Cyclic Chemotherapy
Medical condition: Chemotherapy-induced anemia (CIA)
Disease: Version SOC Term Classification Code Term Level
9.1 10064469 Anemia post chemotherapy LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results
EudraCT Number: 2009-017274-20 Sponsor Protocol Number: 0927 Start Date:
Sponsor Name: Centre Hospitalier Universitaire de GRENOBLE
Full Title: Evaluation de l’efficacité de l’Alfentanil chez l’enfant en réanimation infantile par rapport au Sufentanil - traitement de référence - sur le confort du patient lors de l’aspiration trachéale
Medical condition: confort de l'enfant lors de l'aspiration trachéale en réanimation pédiatrique
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2015-002923-24 Sponsor Protocol Number: R033812GTS3001 Start Date:
Sponsor Name: Janssen-Cilag International NV
Full Title: A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Prospective Study to Evaluate the Safety and Efficacy of Domperidone in 6-month-old to 12-year-old Pediatric Subjects Wi...
Medical condition: Nausea and Vomiting Due to Acute Gastroenteritis
Disease: Version SOC Term Classification Code Term Level
18.1 100000004862 10066762 Acute gastroenteritis LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (Prematurely Ended) PT (Completed) BE (Completed) ES (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended)
Trial results: View results
3